Table 2.
Clinicopathological features of granulocyte colony-stimulating factor (G-CSF)-producing colorectal carcinoma in patients reported in the literature
| Year | Age (y) | Sex | Location | G-CSF (pg/mL) | WBC (cells/mm3) | Histology | Outcome |
|---|---|---|---|---|---|---|---|
| 2002 [22] | 71 | M | A | NA | 29,400 | Moderately diff. adenoca | Died after 5 months |
| 2008 [9] | 57 | M | R | 840 | 81,000 | Undiff. ca. | Died after 2 months |
| 2009 [8] | 52 | M | A | 640 | 63,000 | Poorly diff. ca. | Died after 1 month |
| 2011 [23] | 81 | M | A | 334 | 17,620 | Poorly diff. ca. | Alive after 24 months |
| Present case | 93 | F | D | 38,090 | Undiff. ca. (GCC-like) | Died after 3 months |
A, ascending colon; R, rectum; D, descending colon; NA, not available; diff., differentiated; ca., carcinoma; GCC, giant cell carcinoma.